SEC Info - La Jolla Pharmaceutical Co. - ‘8-K’ for 11/1/20

SEC Info℠

Home

Help

Please Sign In

La Jolla Pharmaceutical Co. – ‘8-K’ for 11/1/20 – ‘EX-16.1’

On: Thursday, 11/5/20, at 4:58pm ET · For: 11/1/20 · Accession #: 1564590-20-51438 · File #: 1-36282

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/05/20  La Jolla Pharmaceutical Co.       8-K:4,9    11/01/20   11:163K                                   ActiveDisclosure/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 2: EX-16.1     Letter re: a Change in Accountant                   HTML      7K 
 7: R1          Document and Entity Information                     HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- ljpc-8k_20201101_htm                XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- ljpc-20201101_lab                     XML     58K 
 5: EX-101.PRE  XBRL Presentations -- ljpc-20201101_pre              XML     35K 
 3: EX-101.SCH  XBRL Schema -- ljpc-20201101                         XSD     18K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    20K 
11: ZIP         XBRL Zipped Folder -- 0001564590-20-051438-xbrl      Zip     11K

‘EX-16.1’ — Letter re: a Change in Accountant

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

<! C:

Exhibit 16.1

November 5, 2020

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Dear Ladies and Gentlemen:

We are the former independent registered public accounting firm for La Jolla Pharmaceutical Company (the “Company”). We have read the Company’s disclosure set forth in Item 4.01 “Changes in Registrant’s Certifying Accountant” of the Company’s Current Report on Form 8-K dated November 1, 2020 (the “Current Report”) and are in agreement with the disclosure in the Current Report, insofar as it pertains to our firm.

Sincerely,

/s/ Squar Milner LLP

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on:	11/5/20	4
For Period end:	11/1/20
		List all Filings

↑Top

Filing Submission 0001564590-20-051438 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)